Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Dermatology Reports
Published in: Current Dermatology Reports 3/2016

01-09-2016 | Laser Therapy (J Jagdeo, Section Editor)

An Update on Combination Treatments with Fractional Resurfacing Lasers

Authors: Melissa Kanchanapoomi Levin, Margit Lai Wun Juhasz, Ellen S. Marmur

Published in: Current Dermatology Reports | Issue 3/2016

Login to get access

Abstract

Purpose of the Review

This article serves to review the newest combination approaches of fractionated resurfacing lasers with other treatment modalities and highlights our clinical pearls.

Recent Findings

Combination therapies with fractionated lasers include treatments with transdermal drug delivery, radiofrequency, light-based devices, photodynamic therapy, and transdermal acoustic pressure.

Summary

Fractional resurfacing lasers revolutionized the laser skin resurfacing surgery by offering similar clinical outcomes to ablative lasers with fewer side effects and less post-treatment downtime. Fractionated lasers are the pillar of skin resurfacing treatments for photodamaged skin such as rhytides, lentigines, and dermal elastosis, actinic damage, and other dermatologic conditions, including acne, rosacea, and scars.
Literature
1.••
Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34(5):426–38. One of the first papers to describe fractional photothermolysis and mechanism of action.PubMedCrossRef
2.
Nino M, Calabrò G, Santoianni P. Topical delivery of active principles: the field of dermatological research. Dermatol Online J. 2010;16(1):4.PubMed
3.
Potts RO, Francoeur ML. The influence of stratum corneum morphology on water permeability. J Invest Dermatol. 1991;96(4):495–9.PubMedCrossRef
4.
Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res. 1991;24:1–26.PubMed
5.
Hantash BM, Bedi VP, Kapadia B, Rahman Z, Jiang K, Tanner H, et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med. 2007;39(2):96–107.PubMedCrossRef
6.
7.
Waibel J, Beer K, Narurkar V, Alster T. Preliminary observations on fractional ablative resurfacing devices: clinical impressions. J Drugs Dermatol JDD. 2009;8(5):481–5.PubMed
8.
9.•
Haedersdal M, Sakamoto FH, Farinelli WA, Doukas AG, Tam J, Anderson RR. Fractional CO(2) laser-assisted drug delivery. Lasers Surg Med. 2010;42(2):113–22. Early study demonstrating enhanced delivery and uptake of methyl 5-aminolevulinate (MAL) as a test drug, creating a foundation of future laser-assisted drug delivery applications for other topical medications.PubMedCrossRef
10.
Waibel JS, Rudnick A, Nousari C, Bhanusali DG. Fractional ablative laser followed by transdermal acoustic pressure wave device to enhance the drug delivery of aminolevulinic acid: in vivo fluorescence microscopy study. J Drugs Dermatol JDD. 2016;15(1):14–21.PubMed
11.
Park JM, Jeong K-H, Bae MI, Lee S-J, Kim N-I, Shin MK. Fractional radiofrequency combined with sonophoresis to facilitate skin penetration of 5-aminolevulinic acid. Lasers Med Sci. 2016;31(1):113–8.PubMedCrossRef
12.
Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2004;30(2 Pt 2):264–71.
13.
Morton CA, McKenna KE, Rhodes LE, British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008;159(6):1245–66.PubMedCrossRef
14.
Braathen LR, Szeimies R-M, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007;56(1):125–43.PubMedCrossRef
15.
Waibel JS, Wulkan AJ, Shumaker PR. Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery. Lasers Surg Med. 2013;45(3):135–40.PubMedCrossRef
16.
Cavalié M, Sillard L, Montaudié H, Bahadoran P, Lacour J-P, Passeron T. Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases. Dermatol Ther. 2015;28(2):74–8.PubMedCrossRef
17.
Babilas P, Schreml S, Szeimies R-M, Landthaler M. Intense pulsed light (IPL): a review. Lasers Surg Med. 2010;42(2):93–104.PubMedCrossRef
18.
Haedersdal M, Katsnelson J, Sakamoto FH, Farinelli WA, Doukas AG, Tam J, et al. Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment. Lasers Surg Med. 2011;43(8):804–13.PubMedCrossRef
19.
Haedersdal M, Sakamoto FH, Farinelli WA, Doukas AG, Tam J, Anderson RR. Pretreatment with ablative fractional laser changes kinetics and biodistribution of topical 5-aminolevulinic acid (ALA) and methyl aminolevulinate (MAL). Lasers Surg Med. 2014;46(6):462–9.PubMedCrossRef
20.
Togsverd-Bo K, Haak CS, Thaysen-Petersen D, Wulf HC, Anderson RR, Hædersdal M, et al. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial. Br J Dermatol. 2012;166(6):1262–9.PubMedCrossRef
21.
Helsing P, Togsverd-Bo K, Veierød MB, Mørk G, Haedersdal M. Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands. Br J Dermatol. 2013;169(5):1087–92.PubMedCrossRef
22.
KE Karmisholt, M Haedersdal. Ablative fractional laser intensifies treatment outcome of scalp actinic keratoses with ingenol mebutate: a case report. J Eur Acad Dermatol Venereol. p. n/a–n/a, 2015.
23.
24.
Sotiriou E, Apalla Z, Chovarda E, Panagiotidou D, Ioannides D. Photodynamic therapy with 5-aminolevulinic acid in actinic cheilitis: an 18-month clinical and histological follow-up. J Eur Acad Dermatol Venereol JEADV. 2010;24(8):916–20.PubMedCrossRef
25.
Choi SH, Kim KH, Song K-H. Efficacy of ablative fractional laser-assisted photodynamic therapy for the treatment of actinic cheilitis: 12-month follow-up results of a prospective, randomized, comparative trial. Br J Dermatol. 2015;173(1):184–91.PubMedCrossRef
26.
Nguyen BT, Gan SD, Konnikov N, Liang CA. Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil. J Am Acad Dermatol. 2015;72(3):558–60.PubMedCrossRef
27.
Ko DY, Kim KH, Song KH. A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up. Br J Dermatol. 2014;170(1):165–72.PubMedCrossRef
28.
Avram MM, Tope WD, Yu T, Szachowicz E, Nelson JS. Hypertrophic scarring of the neck following ablative fractional carbon dioxide laser resurfacing. Lasers Surg Med. 2009;41(3):185–8.PubMedPubMedCentralCrossRef
29.
Monstrey S, Middelkoop E, Vranckx JJ, Bassetto F, Ziegler UE, Meaume S, et al. Updated scar management practical guidelines: non-invasive and invasive measures. J Plast Reconstr Aesthetic Surg JPRAS. 2014;67(8):1017–25.PubMedCrossRef
30.•
Sklar LR, Burnett CT, Waibel JS, Moy RL, Ozog DM. Laser assisted drug delivery: a review of an evolving technology. Lasers Surg Med. 2014;46(4):249–62. Comprehensive review that offers clinical applications of laser-assisted drug delivery.PubMedCrossRef
31.
Butterwick K, Lowe NJ. Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience. J Am Acad Dermatol. 2009;61(2):281–93.PubMedCrossRef
32.
Waibel J, Beer K. Ablative fractional laser resurfacing for the treatment of a third-degree burn. J Drugs Dermatol JDD. 2009;8(3):294–7.PubMed
33.
Kates LC, Fitzgerald R. Poly-L-lactic acid injection for HIV-associated facial lipoatrophy: treatment principles, case studies, and literature review. Aesthetic Surg J Am Soc Aesthetic Plast Surg. 2008;28(4):397–403.CrossRef
34.
Rkein A, Ozog D, Waibel JS. Treatment of atrophic scars with fractionated CO2 laser facilitating delivery of topically applied poly-L-lactic acid. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2014;40(6):624–31.
35.
Wang L, Tai N-Z, Fan Z-H. Effect of botulinum toxin type A injection on hypertrophic scar in rabbit ear model. Zhonghua Zheng Xing Wai Ke Za Zhi Zhonghua Zhengxing Waike Zazhi Chin J Plast Surg. 2009;25(4):284–7.
36.
M Chen, T Yan, K Ma, L Lai, C Liu, L Liang, X Fu. Botulinum toxin type a inhibits α-smooth muscle actin and myosin II expression in fibroblasts derived from scar contracture. Ann Plast Surg. 2014.
37.
Shaarawy E, Hegazy RA, Abdel Hay RM. Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial. J Cosmet Dermatol. 2015;14(2):161–6.PubMedCrossRef
38.
Beer K, Waibel J. Botulinum toxin type A enhances the outcome of fractional resurfacing of the cheek. J Drugs Dermatol JDD. 2007;6(11):1151–2.PubMed
39.
Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1–S50.PubMedCrossRef
40.
41.
Barolet D, Boucher A. Radiant near infrared light emitting Diode exposure as skin preparation to enhance photodynamic therapy inflammatory type acne treatment outcome. Lasers Surg Med. 2010;42(2):171–8.PubMedCrossRef
42.
Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol. 2006;54(4):647–51.PubMedCrossRef
43.
Orringer JS, Sachs DL, Bailey E, Kang S, Hamilton T, Voorhees JJ. Photodynamic therapy for acne vulgaris: a randomized, controlled, split-face clinical trial of topical aminolevulinic acid and pulsed dye laser therapy. J Cosmet Dermatol. 2010;9(1):28–34.PubMedCrossRef
44.
Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Br J Dermatol. 2006;154(5):969–76.PubMedCrossRef
45.
Yeung CK, Shek SY, Bjerring P, Yu CS, Kono T, Chan HH. A comparative study of intense pulsed light alone and its combination with photodynamic therapy for the treatment of facial acne in Asian skin. Lasers Surg Med. 2007;39(1):1–6.PubMedCrossRef
46.
Gürbüz A, Özhan G, Güngör S, Erdal MS. Colloidal carriers of isotretinoin for topical acne treatment: skin uptake, ATR-FTIR and in vitro cytotoxicity studies. Arch Dermatol Res. 2015;307(7):607–15.PubMedCrossRef
47.
Dahan S. Laser and intense pulsed light management of couperose and rosacea. Ann Dermatol Vénéréologie. 2011;138 Suppl 3:S219–22.CrossRef
48.
Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol. 2008;58(5):719–37. quiz 738–740.PubMedCrossRef
49.
50.
Booth BA, Uitto J. Collagen biosynthesis by human skin fibroblasts. III. The effects of ascorbic acid on procollagen production and prolyl hydroxylase activity. Biochim Biophys Acta. 1981;675(1):117–22.PubMedCrossRef
51.
Lin F-H, Lin J-Y, Gupta RD, Tournas JA, Burch JA, Selim MA, et al. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. J Invest Dermatol. 2005;125(4):826–32.PubMedCrossRef
52.
S Waibel, Q-S Mi, D Ozog, L Qu, L Zhou, A Rudnick, F Al-Niaimi, J Woodward, V Campos, S Mordon. Laser-assisted delivery of vitamin C, vitamin E, and ferulic acid formula serum decreases fractional laser postoperative recovery by increased beta fibroblast growth factor expression. Lasers Surg Med. 2015.
53.
Kim H, Gallo J. Evaluation of the effect of platelet-rich plasma on recovery after ablative fractional photothermolysis. JAMA Facial Plast Surg. 2015;17(2):97–102.PubMedCrossRef
54.
Tao L, Wu J, Qian H, Lu Z, Li Y, Wang W, et al. Intense pulsed light, near infrared pulsed light, and fractional laser combination therapy for skin rejuvenation in Asian subjects: a prospective multi-center study in China. Lasers Med Sci. 2015;30(7):1977–83.PubMedCrossRef
Metadata
Title
An Update on Combination Treatments with Fractional Resurfacing Lasers
Authors
Melissa Kanchanapoomi Levin
Margit Lai Wun Juhasz
Ellen S. Marmur
Publication date
01-09-2016
Publisher
Springer US
Published in
Current Dermatology Reports / Issue 3/2016
Electronic ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-016-0145-6

Other articles of this Issue 3/2016

Current Dermatology Reports 3/2016 Go to the issue

Laser Therapy (J Jagdeo, Section Editor)

Laser Revision and Rehabilitation of Mohs Micrographic Surgical Scars

Laser Therapy (J Jagdeo, Section Editor)

A Combination Approach with Lasers, Light, and Energy-Based Devices for Ultimate Rejuvenation of the Aging Face

Medical Surgery (M Alam, Section Editor)

Premedication, Sedation, and Pain Medication in Dermatologic Surgery

Laser Therapy (J Jagdeo, Section Editor)

Tattoos and Beyond: the Clinical Evolution of Picosecond Laser Technology

Laser Therapy (J Jagdeo, Section Editor)

The Evolution and Current Best Treatments for Traumatic, Surgical, and Burn Scars

Laser Therapy (J Jagdeo, Section Editor)

How Wounding via Lasers Has Potential Photocarcinogenic Preventative Effects via Dermal Remodeling